Clinical trials
Withdrawn Phase 1 Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 6 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| GlaxoSmithKline | 4 |
| Bristol-Myers Squibb | 3 |
| M.D. Anderson Cancer Center | 3 |
| Amgen | 2 |
| AstraZeneca | 2 |
| Dartmouth-Hitchcock Medical Center | 2 |
| Emory University | 2 |
| Hoffmann-La Roche | 2 |
| INSYS Therapeutics Inc | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 69 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma | 5 |
| Brain Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Recurrence | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Neoplasm Metastasis | 3 |
| Osteosarcoma | 3 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.